Pristyn Care
Capital The Cityscape, Badshahpur, Sector 66, Gurugram, Haryana, 122102, India
Overview
Pristyn Care is a Gurugram-based healthtech company focused on secondary-care surgical services delivered through its clinics and partner hospitals. It operates via 150+ clinics and 700+ partner hospitals with a panel of 300+ experienced doctors who work exclusively for the company. The startup says it has scaled 5X since January 2021 and expects to be profitable within the next 12–18 months. Pristyn Care plans to expand to 50+ cities/towns and reach 1,000+ surgical centres and five million patient interactions by March 2022, while doubling its team and hiring engineers to form a quarter of new hires. The company intends to invest the new capital in adopting advanced surgical technologies, expanding into new disease categories, modernising partner-hospital infrastructure, training surgeons, and further developing its product and technology. Pristyn Care is a Gurugram-based healthcare startup. The company announced a $53 million Series D round led by US-based hedge fund Tiger Global Management. After the raise, its valuation more than doubled to $550 million in six months. The article identifies the fundraise and valuation change but does not detail the company’s specific services, operating metrics, or future plans. No additional investor names, prior rounds, or use-of-proceeds details are provided in the article. Pristyn Care is described in the article as a healthcare startup. The article does not provide details about the company’s core products, services, or operating metrics. It announced that it has raised $12 million in a Series B funding round. The round was reported to be led by Sequoia Capital India, Hummingbird Ventures, Greenoaks Capital and AngelList. The article does not specify use of proceeds, future plans, past rounds, founding year, or location.
- Total raised
- $161M
- Funding rounds
- 3
- Latest round
- Series E
- Latest activity
- Dec 2021
Industries
- Health Care
- Hospital
- Internet
Recent funding
Series E
Dec 2021
$96M
Series D
Apr 2021
$53M
Series B
Dec 2019
$12M